Pain in Patients With Cystic Fibrosis in Rouen University Hospital
NCT ID: NCT04561973
Last Updated: 2022-02-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
109 participants
OBSERVATIONAL
2019-11-04
2020-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
\- To evaluate the intensity and frequency of pain episodes in patients with cystic fibrosis followed at the cystic fibrosis center of Rouen University Hospital, Normandy, France.
Objectifs secondaires
* To assess the relationship between pain and disease severity.
* To assess the relationship between pain and the age of the patient.
* To describe the pain locations.
* To describe the use of pharmacological or nonpharmacological treatment.
* To evaluate the procedural pain.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Psychological Study in Children With Mucoviscidosis
NCT05948488
Physical Activity Profile and Sedentary Behaviour in Adults With Cystic Fibrosis
NCT06507956
Extrapulmonary Effects of Cystic Fibrosis on Physical Activity of Adult Patients.
NCT01848392
Respiratory Muscle Training in CF Patients
NCT03190031
Determinants of Daily Physical Activity Level in Patients With Cystic Fibrosis - Pilot Study Protocol
NCT05206097
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary evaluation criteria :
Intensity and frequency of pain are evaluated with the prospective diary.
* The pain intensity is assessed by validated scales adapted to the patient's age (scale ranging from 0 to 10).
0 to 6 years : numerical rating scale assessed by the parents. 4 to 7 years : Faces Pain Scale Revised. Children 6 years and older, adolescents and adults: numerical rating scale self-reported
* The pain frequency is completed twice a day (morning and evening) on the prospective pain diary.
Secondary evaluation criteria
* The disease severity, estimated using recent forced expiratory volume in one second (FEV1) (best measurement of the year before bronchodilator, collected in the patient's medical record)
* Pain locations, pharmacological or nonpharmacological treatment and procedural pain are evaluated using the diary and the questionnaire.
* Demographic data and characteristics of cystic fibrosis are collected using the medical file.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
numerical rating scale
Patients seen for routine planned visits complete a self-administered retrospective questionnaire about pain during the last 3 months, and a prospective diary during the two weeks following the visit.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Seen for routine planned visits.
* Having expressed their non-opposition or whose non-opposition was expressed by the parents or legal representatives for minors
Exclusion Criteria
* Major patient under legal protection.
* Major patient having problems understanding the oral and written French language or child whose parents or legal representatives have problems understanding the oral and written French language.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Rouen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU
Rouen, Nomandie, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019/318/OB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.